News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University…